相似文献
1
HLA DR antigens and gold toxicity.
Ann Rheum Dis. 1983 Feb;42(1):63-6. doi: 10.1136/ard.42.1.63.
2
HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
J Rheumatol. 1984 Jun;11(3):358-61.
3
HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Clin Rheumatol. 1985 Mar;4(1):55-61. doi: 10.1007/BF02032318.
4
HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
Ann Rheum Dis. 1989 Jul;48(7):539-41. doi: 10.1136/ard.48.7.539.
5
HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
J Rheumatol. 1984 Oct;11(5):610-4.
6
Risk factors in the treatment of rheumatoid arthritis with parenteral gold.
Scand J Rheumatol Suppl. 1983;51:112-5. doi: 10.3109/03009748309095362.
7
Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
J Rheumatol. 1994 Jan;21(1):41-3.
8
DR antigens and gold toxicity in white rheumatoid arthritis patients.
Arthritis Rheum. 1984 Jun;27(6):601-5. doi: 10.1002/art.1780270601.
9
HLA DR antigens and disease expression in rheumatoid arthritis.
Ann Rheum Dis. 1984 Apr;43(2):218-21. doi: 10.1136/ard.43.2.218.
10
HLA-A,-B, and -DR antigens in relation to gold and D-penicillamine toxicity in Greek patients with RA.
Dis Markers. 1986 Jun;4(1-2):35-41.
引用本文的文献
1
Endogenous retroviruses drive species-specific germline transcriptomes in mammals.
Nat Struct Mol Biol. 2020 Oct;27(10):967-977. doi: 10.1038/s41594-020-0487-4. Epub 2020 Sep 7.
2
Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.
Inflammopharmacology. 2013 Aug;21(4):291-300. doi: 10.1007/s10787-013-0173-9. Epub 2013 May 19.
3
Metals and kidney autoimmunity.
Environ Health Perspect. 1999 Oct;107 Suppl 5(Suppl 5):753-65. doi: 10.1289/ehp.99107s5753.
4
Drug-induced "allergic hepatitis".
Clin Rev Allergy Immunol. 1995 Fall;13(3):223-44. doi: 10.1007/BF02771763.
5
Gold induced nephropathy in rheumatoid arthritis and HLA class II genes.
Ann Rheum Dis. 1993 Apr;52(4):300-1. doi: 10.1136/ard.52.4.300.
6
HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
Ann Rheum Dis. 1985 Sep;44(9):621-4. doi: 10.1136/ard.44.9.621.
7
HLA antigens and seronegative rheumatoid arthritis.
Ann Rheum Dis. 1985 Jan;44(1):50-3. doi: 10.1136/ard.44.1.50.
8
9
HLA antigens and gold toxicity in American blacks with rheumatoid arthritis.
Rheumatol Int. 1986;6(1):13-7. doi: 10.1007/BF00270659.
10
Association of different HLA antigens with various toxic effects of gold salts in rheumatoid arthritis.
Ann Rheum Dis. 1986 Mar;45(3):177-82. doi: 10.1136/ard.45.3.177.
本文引用的文献
1
1958 Revision of diagnostic criteria for rheumatoid arthritis.
Bull Rheum Dis. 1958 Dec;9(4):175-6.
2
[Complications of gold therapy in rheumatoid arthritis].
Duodecim. 1957;73(10):597-608.
3
HLA-DRw3 and systemic lupus erythematosus.
Arthritis Rheum. 1980 Aug;23(8):954-7. doi: 10.1002/art.1780230815.
4
Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.
Arthritis Rheum. 1980 Nov;23(11):1241-5. doi: 10.1002/art.1780231102.
5
HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
N Engl J Med. 1980 Aug 7;303(6):300-2. doi: 10.1056/NEJM198008073030602.
6
Gold nephropathy prototype of membranous glomerulonephritis.
Am J Pathol. 1974 Jun;75(3):573-90.
7
Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.
Br Med J. 1978 Nov 11;2(6148):1326-8. doi: 10.1136/bmj.2.6148.1326.
8
The human major histocompatibility complex HLA: some recent developments.
Transplant Proc. 1979 Mar;11(1):616-23.
Zotero 插件